Hsbc Holdings PLC Eli Lilly & CO Transaction History

Hsbc Holdings PLC

$145 Billion
Q1 2024

A detailed history of Hsbc Holdings PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hsbc Holdings PLC holds 2,185,819 shares of LLY stock, worth $1.98 Billion. This represents 1.17% of its overall portfolio holdings.

Number of Shares

2,185,819

Previous 1,748,653 25.0%

Holding current value

$1.98 Billion

Previous $1.02 Billion 66.82%

% of portfolio

1.17%

Previous 0.9%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $259 Million - $346 Million	437,166 Added 25.0%	2,185,819 $1.7 Billion
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $125 Million - $148 Million	238,660 Added 15.81%	1,748,653 $1.02 Billion
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $56.8 Million - $78.4 Million	130,779 Added 9.48%	1,509,993 $811 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $41.5 Million - $55.5 Million	118,428 Added 9.39%	1,379,214 $647 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $35.6 Million - $41.8 Million	-114,669 Reduced 8.34%	1,260,786 $433 Million

Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $159 Million - $185 Million	494,047 Added 56.05%	1,375,455 $503 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $53.1 Million - $60.5 Million	-178,999 Reduced 16.88%	881,408 $288 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $41 Million - $48.1 Million	146,946 Added 16.09%	1,060,407 $344 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $11.8 Million - $14.6 Million	-50,070 Reduced 5.2%	913,461 $263 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $20.8 Million - $25.8 Million	-92,576 Reduced 8.77%	963,531 $266 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $2.34 Million - $2.87 Million	-10,538 Reduced 0.99%	1,056,107 $244 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $13.7 Million - $17.8 Million	-76,068 Reduced 6.66%	1,066,645 $245 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $11.5 Million - $14.9 Million	-70,151 Reduced 5.78%	1,142,713 $213 Million
Q4 2020 Feb 25, 2021	SELL	$130.46 - $172.63 $8.18 Million - $10.8 Million	-62,700 Reduced 4.92%	1,212,864 $205 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $26.1 Million - $34.5 Million	199,924 Added 18.59%	1,275,564 $215 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $31.3 Million - $36.2 Million	214,009 Added 24.84%	1,075,640 $159 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $11.8 Million - $14.1 Million	-86,175 Reduced 9.09%	861,631 $141 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $5.13 Million - $6.35 Million	-43,078 Reduced 4.35%	947,806 $131 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $10.9 Million - $13.5 Million	101,577 Added 11.42%	990,884 $131 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $1.13 Million - $1.22 Million	-10,539 Reduced 1.17%	889,307 $99.5 Million
Q2 2019 Aug 13, 2019	BUY	$110.79 - $129.32 $6.91 Million - $8.06 Million	62,334 Added 7.44%	899,846 $99.7 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $8.31 Million - $9.79 Million	-74,701 Reduced 8.19%	837,512 $109 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $26.1 Million - $29.2 Million	-246,145 Reduced 21.25%	912,213 $105 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $7.78 Million - $9.72 Million	-90,602 Reduced 7.25%	1,158,358 $124 Million
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $64.4 Million - $73.9 Million	-850,181 Reduced 40.5%	1,248,960 $107 Million
Q1 2018 May 11, 2018	BUY	$74.21 - $87.6 $548,782 - $647,802	7,395 Added 0.35%	2,099,141 $162 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $20.7 Million - $22.2 Million	252,743 Added 13.74%	2,091,746 $177 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $22.7 Million - $25.2 Million	294,233 Added 19.05%	1,839,003 $157 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,544,770	1,544,770 $127 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Eli Lilly & CO Transaction History